Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study. Li AC, Lin YC, Huang JY, Chen LC, et al. PLoS One 2025;20:e0326534.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li AC, Lin YC, Huang JY, Chen LC, et al. Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study. PLoS One 2025;20:e0326534.
PMID: 40570020